IBL C1Q-CIC CIA TEST
K-Number: K032254 · 2003-08-29
Advertisement
Device Summary
Frequently Asked Questions
What is the IBL C1Q-CIC CIA TEST?
IBL C1Q-CIC CIA TEST is a medical device that received FDA 510(k) clearance on 2003-08-29. The listed applicant is Ibl GmbH. The 510(k) number is K032254.
When did IBL C1Q-CIC CIA TEST receive FDA 510(k) clearance?
IBL C1Q-CIC CIA TEST received FDA 510(k) clearance on 2003-08-29, under 510(k) number K032254.
Who is the listed applicant for IBL C1Q-CIC CIA TEST?
The FDA 510(k) record lists Ibl GmbH as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for IBL C1Q-CIC CIA TEST?
The FDA product code for IBL C1Q-CIC CIA TEST is DAK.
Other records listing Ibl GmbH as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DAK)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement